cost effectiveness of ‘on demand’ hiv pre-exposure prophylaxis for non-injection drug-using men who have sex with men in canada
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

cost effectiveness of ‘on demand’ hiv pre-exposure prophylaxis for non-injection drug-using men who have sex with men in canada

;Estelle Ouellet;Madeleine Durand;Jason R Guertin;Jacques LeLorier;Cécile L Tremblay
zdravstveno varstvo 2015 Vol. 26 pp. 23-29
203
ouellet2015canadiancost

Abstract

BACKGROUND: Recent trials report the efficacy of continuous tenofovir-based pre-exposure prophylaxis (PrEP) for prevention of HIV infection. The cost effectiveness of ‘on demand’ PrEP for non-injection drug-using men who have sex with men at high risk of HIV acquisition has not been evaluated.

Keywords

infectious and parasitic diseasesmicrobiology

Access

DOI:
10.1155/2015/964512
URL:
http://dx.doi.org/10.1155/2015/964512

Citation

ID: 227494
Ref Key: ouellet2015canadiancost
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
227494
Unique Identifier:
10.1155/2015/964512
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store